Risk factors and outcome of hyperammonaemia in people with epilepsy.

There was a trend towards significance for HA being less common in patients with molecularly confirmed monogenic or metabolic conditions than in those with structural or cryptogenic epilepsy ( P = 0.05): 5/59 individuals had a genetic or metabolic condition in the HA group (i.e. arginase deficiency, carnitine palmitoyltransferase I defi

also in 2,760 other papers

Ammonia levels were only mildly raised and showed a trend towards statistically significant difference from the asymptomatic group.

also in 53,322 other papers